This application seeks to develop and implement exemplary, harmonized procedures for human biosample informed consenting practices and associated biorepository operations at five University of California (UC) medical campuses, all of whom have Clinical and Translational Science Awards (CTSA). The University of California Office of the President (UCOP) has committed to creating a regional research network involving the UC CTSAs at Davis, Irvine, UCLA, San Diego and San Francisco. Critical to the success of this network will be the availability of high quality biosamples and associated clinical data that are obtained and shared in a manner acceptable to the institutional review boards (IRBs) at all five campuses. This application focuses on harmonizing such processes in outpatient clinics, which see the majority of our 12 million covered patients.
We aim to establish an ethical, efficient, and sustainable system for obtaining, processing, and sharing biospecimens and data that can serve as a baseline for future studies and a model for similar programs around the United States. We further aim to ensure that these processes achieve broad stakeholder input and buy-in, including from researchers, clinicians, patients, communities, and institutional officials. We have three specific aims. (1) Engage UC stakeholders (institutional officials, clinicians, investigators, and California's patients and communities) to identify, develop, and refine feasible approaches for (a) obtaining informed consent from outpatients to donate their biosamples to UC biorepositories and (b) handling collection, processing, and sharing of biospecimens and associated clinical data. (2) Compare the performance, in practice, of three alternative procedures for obtaining informed consent for outpatient biorepository studies: standard consent versus Portable Legal Consent (PLC) versus Community Informed Systemwide Consent (CISC). (3) Based on results from Aims 1-2, develop and implement policies and procedures that will create an exemplary system for obtaining and sharing biospecimens and associated data throughout UC in a manner that respects our diverse patient base and uses highest quality informed consent practices.

Public Health Relevance

Biorepositories represent a valuable scientific resource for studies of human disease and treatment even as they present new challenges for the protection of human subjects. The proposed study seeks to develop and implement best practices for human subjects protections for biorespository studies for the diverse communities served by the University of California.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR000004-07S2
Application #
8476360
Study Section
Special Emphasis Panel (ZRG1-HDM-B (90))
Program Officer
Wilde, David B
Project Start
2006-09-30
Project End
2016-06-30
Budget Start
2012-09-24
Budget End
2013-06-30
Support Year
7
Fiscal Year
2012
Total Cost
$2,018,277
Indirect Cost
$250,033
Name
University of California San Francisco
Department
Neurology
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Bhupathiraju, Shilpa N; Guasch-Ferré, Marta; Gadgil, Meghana D et al. (2018) Dietary Patterns among Asian Indians Living in the United States Have Distinct Metabolomic Profiles That Are Associated with Cardiometabolic Risk. J Nutr 148:1150-1159
Brunt, Elizabeth M; Kleiner, David E; Wilson, Laura A et al. (2018) Improvements in Histologic Features and Diagnosis associated with Improvement in Fibrosis in NASH: Results from the NASH Clinical Research Network Treatment Trials. Hepatology :
Averbach, Sarah; Silverberg, Michael J; Leyden, Wendy et al. (2018) Recent intrauterine device use and the risk of precancerous cervical lesions and cervical cancer. Contraception :
Tipton, Laura; Cuenco, Karen T; Huang, Laurence et al. (2018) Measuring associations between the microbiota and repeated measures of continuous clinical variables using a lasso-penalized generalized linear mixed model. BioData Min 11:12
Kober, Kord M; Olshen, Adam; Conley, Yvettte P et al. (2018) Expression of mitochondrial dysfunction-related genes and pathways in paclitaxel-induced peripheral neuropathy in breast cancer survivors. Mol Pain 14:1744806918816462
Huck, Daniel M; Hanna, David B; Rubin, Leah H et al. (2018) Carotid Artery Stiffness and Cognitive Decline Among Women With or at Risk for HIV Infection. J Acquir Immune Defic Syndr 78:338-347
Ghosh, Mimi; Daniels, Jason; Pyra, Maria et al. (2018) Impact of chronic sexual abuse and depression on inflammation and wound healing in the female reproductive tract of HIV-uninfected and HIV-infected women. PLoS One 13:e0198412
Harmatz, Paul; Whitley, Chester B; Wang, Raymond Y et al. (2018) A novel Blind Start study design to investigate vestronidase alfa for mucopolysaccharidosis VII, an ultra-rare genetic disease. Mol Genet Metab 123:488-494
Ficicioglu, Can; Giugliani, Roberto; Harmatz, Paul et al. (2018) Intrafamilial variability in the clinical manifestations of mucopolysaccharidosis type II: Data from the Hunter Outcome Survey (HOS). Am J Med Genet A 176:301-310
Patel, Zubin; Lu, Xiaoming; Miller, Daniel et al. (2018) A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus. Hum Mol Genet :

Showing the most recent 10 out of 662 publications